Commission Implementing Regulation (EU) 2025/99 of 21 January 2025 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances Aureobasidium pullulans (strains DSM 14940 and DSM 14941), Bacillus amyloliquefaciens subsp. plantarum D747, benalaxyl-M, cyprodinil, dichlorprop-P, formetanate, fosetyl, halosulfuron-methyl, imazamox, milbemectin, phenmedipham, pirimicarb, Pseudomonas sp. strain DSMZ 13134, pyrimethanil, pyriofenone, pyroxsulam, spinosad, sulphur, Trichoderma harzianum Rifai strains T-22 and ITEM 908, Trichoderma asperellum (formerly T. harzianum) strains ICC012, T-25 and TV-1, Trichoderma atroviride (formerly T. harzianum) strain T11, Trichoderma gamsii (formerly T. viride) strain ICC080, triticonazole and ziram

• CELEX: Implementing Regulation (EU) 2025/99
• Articles: 3

Article 1

The Annex to Implementing Regulation (EU) No 540/2011 is amended in accordance with the Annex to this Regulation.

Article 2

This Regulation shall enter into force on the third day following that of its publication in the Official Journal of the European Union .

Schedules & Appendices

ANNEX

ANNEX

1.

Part A of the Annex to Implementing Regulation (EU) No 540/2011 is amended as follows:

(1)

in the sixth column, expiration of approval, of row 74, Ziram, the date is replaced by ‘31 January 2027’;

(2)

in the sixth column, expiration of approval, of row 88, Phenmedipham, the date is replaced by ‘30 September 2026’;

(3)

in the sixth column, expiration of approval, of row 110, Milbemectin, the date is replaced by ‘31 May 2026’;

(4)

in the sixth column, expiration of approval, of row 124, Pirimicarb, the date is replaced by ‘31 October 2026’;

(5)

in the sixth column, expiration of approval, of row 127, Triticonazole, the date is replaced by ‘31 January 2027’;

(6)

in the sixth column, expiration of approval, of row 130, Cyprodinil, the date is replaced by ‘31 October 2026’;

(7)

in the sixth column, expiration of approval, of row 131, Fosetyl, the date is replaced by ‘31 October 2026’;

(8)

in the sixth column, expiration of approval, of row 133, Dichlorprop-P, the date is replaced by ‘31 October 2026’;

(9)

in the sixth column, expiration of approval, of row 135, Pyrimethanil, the date is replaced by ‘30 June 2026’;

(10)

in the sixth column, expiration of approval, of row 139, Spinosad, the date is replaced by ‘31 October 2026’;

(11)

in the sixth column, expiration of approval, of row 147, Formetanate, the date is replaced by ‘30 September 2026’;

(12)

in the sixth column, expiration of approval, of row 204, Trichoderma atroviride (formerly T. harzianum ) strain T11, the date is replaced by ‘30 November 2026’;

(13)

in the sixth column, expiration of approval, of row 206, Trichoderma harzianum Rifai strains T-22 and ITEM 908, the date is replaced by ‘30 November 2026’;

(14)

in the sixth column, expiration of approval, of row 207, Trichoderma asperellum (formerly T. harzianum ) strains ICC012, T-25 and TV-1, the date is replaced by ‘30 November 2026’;

(15)

in the sixth column, expiration of approval, of row 208, Trichoderma gamsii (formerly T. viride ) strain ICC080, the date is replaced by ‘30 November 2026’;

(16)

in the sixth column, expiration of approval, of row 292, Sulphur, the date is replaced by ‘31 July 2026’.

2.

Part B of the Annex to Implementing Regulation (EU) No 540/2011 is amended as follows:

(1)

in the sixth column, expiration of approval, of row 35, Halosulfuron-methyl, the date is replaced by ‘15 November 2026’;

(2)

in the sixth column, expiration of approval, of row 50, Pseudomonas sp. strain DSMZ 13134, the date is replaced by ‘30 June 2027’;

(3)

in the sixth column, expiration of approval, of row 52, Aureobasidium pullulans (strains DSM 14940 and DSM 14941), the date is replaced by ‘30 June 2027’;

(4)

in the sixth column, expiration of approval, of row 53, Pyriofenone, the date is replaced by ‘30 June 2027’;

(5)

in the sixth column, expiration of approval, of row 58, Benalaxyl-M, the date is replaced by ‘30 September 2027’;

(6)

in the sixth column, expiration of approval, of row 61, Pyroxsulam, the date is replaced by ‘30 September 2027’;

(7)

in the sixth column, expiration of approval, of row 83, Bacillus amyloliquefaciens subsp. plantarum D747, the date is replaced by ‘31 August 2027’.

3.

In Part E of the Annex to Implementing Regulation (EU) No 540/2011, in the sixth column, expiration of approval, of row 8, Imazamox, the date is replaced by ‘30 June 2027’.